176 related articles for article (PubMed ID: 35947079)
1. Transatlantic Comparison of Pediatric Continuous Glucose Monitoring Use in the Diabetes-Patienten-Verlaufsdokumentation Initiative and Type 1 Diabetes Exchange Quality Improvement Collaborative.
DeSalvo DJ; Lanzinger S; Noor N; Steigleder-Schweiger C; Ebekozien O; Sengbusch SV; Yayah Jones NH; Laubner K; Maahs DM; Holl RW
Diabetes Technol Ther; 2022 Dec; 24(12):920-924. PubMed ID: 35947079
[TBL] [Abstract][Full Text] [Related]
2. Continuous glucose monitoring and glycemic control among youth with type 1 diabetes: International comparison from the T1D Exchange and DPV Initiative.
DeSalvo DJ; Miller KM; Hermann JM; Maahs DM; Hofer SE; Clements MA; Lilienthal E; Sherr JL; Tauschmann M; Holl RW;
Pediatr Diabetes; 2018 Nov; 19(7):1271-1275. PubMed ID: 29923262
[TBL] [Abstract][Full Text] [Related]
3. Temporal Changes in Hemoglobin A1c and Diabetes Technology Use in DPV, NPDA, and T1DX Pediatric Cohorts from 2010 to 2018.
Lal RA; Robinson H; Lanzinger S; Miller KM; Pons Perez S; Kovacic R; Calhoun P; Campbell F; Naeke A; Maahs DM; Holl RW; Warner J
Diabetes Technol Ther; 2022 Sep; 24(9):628-634. PubMed ID: 35856740
[No Abstract] [Full Text] [Related]
4. Patient Demographics and Clinical Outcomes Among Type 1 Diabetes Patients Using Continuous Glucose Monitors: Data From T1D Exchange Real-World Observational Study.
DeSalvo DJ; Noor N; Xie C; Corathers SD; Majidi S; McDonough RJ; Polsky S; Izquierdo R; Rioles N; Weinstock R; Obrynba K; Roberts A; Vendrame F; Sanchez J; Ebekozien O
J Diabetes Sci Technol; 2023 Mar; 17(2):322-328. PubMed ID: 34632823
[TBL] [Abstract][Full Text] [Related]
5. Five heterogeneous HbA1c trajectories from childhood to adulthood in youth with type 1 diabetes from three different continents: A group-based modeling approach.
Clements MA; Schwandt A; Donaghue KC; Miller K; Lück U; Couper JJ; Foster N; Schröder C; Phelan H; Maahs D; Prinz N; Craig ME;
Pediatr Diabetes; 2019 Nov; 20(7):920-931. PubMed ID: 31418521
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Trends in Glycemic Outcomes and Technology Use for Over 48,000 People with Type 1 Diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative.
Ebekozien O; Mungmode A; Sanchez J; Rompicherla S; Demeterco-Berggren C; Weinstock RS; Jacobsen LM; Davis G; McKee A; Akturk HK; Maahs DM; Kamboj MK
Diabetes Technol Ther; 2023 Nov; 25(11):765-773. PubMed ID: 37768677
[No Abstract] [Full Text] [Related]
7. Glycemic Outcomes with Early Initiation of Continuous Glucose Monitoring System in Recently Diagnosed Patients with Type 1 Diabetes.
Mulinacci G; Alonso GT; Snell-Bergeon JK; Shah VN
Diabetes Technol Ther; 2019 Jan; 21(1):6-10. PubMed ID: 30575413
[TBL] [Abstract][Full Text] [Related]
8. Effect of Continuous Glucose Monitoring on Glycemic Control in Adolescents and Young Adults With Type 1 Diabetes: A Randomized Clinical Trial.
Laffel LM; Kanapka LG; Beck RW; Bergamo K; Clements MA; Criego A; DeSalvo DJ; Goland R; Hood K; Liljenquist D; Messer LH; Monzavi R; Mouse TJ; Prahalad P; Sherr J; Simmons JH; Wadwa RP; Weinstock RS; Willi SM; Miller KM; ;
JAMA; 2020 Jun; 323(23):2388-2396. PubMed ID: 32543683
[TBL] [Abstract][Full Text] [Related]
9. Continuous Glucose Monitoring in Adults with Type 1 Diabetes: Real-World Data from the German/Austrian Prospective Diabetes Follow-Up Registry.
Sandig D; Grimsmann J; Reinauer C; Melmer A; Zimny S; Müller-Korbsch M; Forestier N; Zeyfang A; Bramlage P; Danne T; Meissner T; Holl RW
Diabetes Technol Ther; 2020 Aug; 22(8):602-612. PubMed ID: 32522039
[No Abstract] [Full Text] [Related]
10. Dynamics of Hemoglobin A1c, Body Mass Index, and Rates of Severe Hypoglycemia in 4434 Adults with Type 1 or Type 2 Diabetes After Initiation of Continuous Glucose Monitoring.
Lanzinger S; Best F; Bergmann T; Laimer M; Lipovsky B; Danne T; Zimny S; Bramlage P; Meyhöfer S; Holl RW
Diabetes Technol Ther; 2022 Oct; 24(10):763-769. PubMed ID: 35653726
[No Abstract] [Full Text] [Related]
11. Real-time continuous glucose monitoring among participants in the T1D Exchange clinic registry.
Wong JC; Foster NC; Maahs DM; Raghinaru D; Bergenstal RM; Ahmann AJ; Peters AL; Bode BW; Aleppo G; Hirsch IB; Kleis L; Chase HP; DuBose SN; Miller KM; Beck RW; Adi S;
Diabetes Care; 2014 Oct; 37(10):2702-9. PubMed ID: 25011947
[TBL] [Abstract][Full Text] [Related]
12. Continuous Glucose Monitoring and Glycemic Control in Young Adults with Type 1 Diabetes: Benefit for Even the Simplest Insulin Administration Methods.
Toschi E; Atakov-Castillo A; Clift A; Bennetti M; Gabbay RA
Diabetes Technol Ther; 2021 Aug; 23(8):586-589. PubMed ID: 33729833
[TBL] [Abstract][Full Text] [Related]
13. Diabetes Device Use and Glycemic Control among Youth with Type 1 Diabetes: A Single-Center, Cross-Sectional Study.
Sheikh K; Bartz SK; Lyons SK; DeSalvo DJ
J Diabetes Res; 2018; 2018():5162162. PubMed ID: 30151393
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Hemoglobin A1c before and after initiation of continuous glucose monitoring in children with type 1 diabetes mellitus.
Gurnurkar S; Owens L; Chalise S; Vyas N
J Pediatr Endocrinol Metab; 2021 Mar; 34(3):311-317. PubMed ID: 33618445
[TBL] [Abstract][Full Text] [Related]
15. Changes in HbA1c Between 2011 and 2017 in Germany/Austria, Sweden, and the United States: A Lifespan Perspective.
Albanese-O'Neill A; Grimsmann JM; Svensson AM; Miller KM; Raile K; Akesson K; Calhoun P; Biesenbach B; Eeg-Olofsson K; Holl RW; Maahs DM; Hanas R
Diabetes Technol Ther; 2022 Jan; 24(1):32-41. PubMed ID: 34524026
[No Abstract] [Full Text] [Related]
16. Continuous glucose monitoring reduces pubertal hyperglycemia of type 1 diabetes.
Nwosu BU; Yeasmin S; Ayyoub S; Rupendu S; Villalobos-Ortiz TR; Jasmin G; Parajuli S; Zahedi B; Zitek-Morrison E; Alonso LC; Barton BA
J Pediatr Endocrinol Metab; 2020 Jul; 33(7):865-872. PubMed ID: 32634109
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends for Diabetes Management and Glycemic Control Between 2010 and 2019 in Korean Children and Adolescents with Type 1 Diabetes.
Choe J; Won SH; Choe Y; Park SH; Lee YJ; Lee J; Lee YA; Lim HH; Yoo JH; Lee SY; Kim EY; Shin CH; Kim JH
Diabetes Technol Ther; 2022 Mar; 24(3):201-211. PubMed ID: 34704794
[No Abstract] [Full Text] [Related]
18. Contrasting the clinical care and outcomes of 2,622 children with type 1 diabetes less than 6 years of age in the United States T1D Exchange and German/Austrian DPV registries.
Maahs DM; Hermann JM; DuBose SN; Miller KM; Heidtmann B; DiMeglio LA; Rami-Merhar B; Beck RW; Schober E; Tamborlane WV; Kapellen TM; Holl RW; ;
Diabetologia; 2014 Aug; 57(8):1578-85. PubMed ID: 24893863
[TBL] [Abstract][Full Text] [Related]
19. Perceived Burdens and Benefits Associated With Continuous Glucose Monitor Use in Type 1 Diabetes Across the Lifespan.
Divan V; Greenfield M; Morley CP; Weinstock RS
J Diabetes Sci Technol; 2022 Jan; 16(1):88-96. PubMed ID: 33356514
[TBL] [Abstract][Full Text] [Related]
20. Improving Continuous Glucose Monitoring Uptake in Underserved Youth with Type 1 Diabetes: The IMPACT Study.
Lin T; Manfredo JA; Illesca N; Abiola K; Hwang N; Salsberg S; Akhtar Y; Mathioudakis N; Brown EA; Wolf RM
Diabetes Technol Ther; 2023 Jan; 25(1):13-19. PubMed ID: 36223197
[No Abstract] [Full Text] [Related]
[Next] [New Search]
